⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2024

Table S5 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER⁺ Breast Cancer

Anran Chen Beom-Jun Kim Aparna Mitra Craig T. Vollert Jonathan T. Lei Diana Fandino Meenakshi Anurag Matthew V. Holt Xuxu Gou Jacob B. Pilcher Matthew P. Goetz Donald W. Northfelt Susan G. Hilsenbeck C. Gary Marshall Marc L. Hyer Robert Papp Shou-Yun Yin Carmine De Angelis Rachel Schiff Suzanne A.W. Fuqua X. Cynthia Charles E. Foulds Matthew J. Ellis

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Statistical analyses of data in Figures 6B, 6C, and S3.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efeea3 https://doi.org/10.1158/1535-7163.27142198

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S3 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
2Figure S4 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
3Table S2 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
4Figure S2 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
5Figures S1 through S19 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024